EPISODE · Aug 20, 2026 · 6 MIN
Dr Gareth Rivalland on promising trial of melanoma vaccine
from RNZ - All Programmes
A deeply compelling innovation has cancer specialists buzzing. An experimental mRNA cancer vaccine which has allowed people with high-risk melanoma to live longer, cancer-free, according to drug companies Moderna and Merck. Medical Oncologist and Melanoma NZ Spokesperson Gareth Rivalland has been leading this from the New Zealand end joined Guyon Espiner to discuss.
Embed this episode
NOW PLAYING
Dr Gareth Rivalland on promising trial of melanoma vaccine
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.